Catalyst Wire Dossier Catalyst Wire Dossier

Lumicitabine

lumicitabine · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Lumicitabine, covering 2018-06-07 to 2021-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection [Phase 2]

See pricing